Aerobic Exercise for Cognitive Functioning in Patients With Substance Use Disorder
SO_CogEx
2 other identifiers
interventional
84
1 country
1
Brief Summary
Impaired cognitive function is common among patients with substance use disorder (SUD). This is particularly related to executive functions (EF), which includes abilities like decision-making, consequence analysis and impulse/self-control. EF is recognized as an important determinant of treatment outcome as it is associated with dropout rate, attendance to therapy sessions and absence of relapse following treatment termination. Exercise seem to improve cognitive/executive functions, particularly in individuals with cognitive impairments. Aerobic exercise also affects signaling substances and growth factors known to inhibit neural degeneration, and improves cerebral insulin sensitivity and blood flow, contributing to improved brain function. There is a lack of knowledge regarding how to improve EF in SUD patients, and whether such improvements can benefit other parts of the treatment, such as psychotherapy. Aerobic exercise is a well-recognized and cost-effective intervention for cardiovascular and metabolic health, with promising effects on cognitive/executive functions. A randomized controlled trial will be carried out to investigate the effects of aerobic exercise on EF, molecular markers of neuroplasticity and brain function, and treatment outcome in SUD patients. The investigators expect to achieve new knowledge regarding cognitive impairment among SUD patients and to what extent aerobic exercise can improve cognitive abilities and treatment outcome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 4, 2022
CompletedStudy Start
First participant enrolled
April 7, 2022
CompletedFirst Posted
Study publicly available on registry
April 12, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 20, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 20, 2024
CompletedJune 10, 2025
June 1, 2025
2.7 years
April 4, 2022
June 5, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in executive function (EF)
Change in executive function assessed with Behavior Rating Inventory of ExecutiveFunction, Adult (BRIEF-A). BRIEF-A is a 75-item standardized questionnaire appraising EFs in real-life situations. It incorporates self-reported cognitive characteristics and collects subjective information about the ability to maintain appropriate control of emotional responses and behavior.
8 weeks
Secondary Outcomes (12)
Change in Montreal Cognitive Assessment (MoCA) score
8 weeks
Change in Stroop test score
8 weeks
Change in Digit Span test performance
8 weeks
Altered serum concentration of Brain Derived Neurotrophic Factor (BDNF)
8 weeks
Altered serum concentration of Klotho
8 weeks
- +7 more secondary outcomes
Study Arms (2)
Exercise intervention group
EXPERIMENTALParticipants will undergo supervised treadmill exercise three times each week for eight weeks, in addition to treatment as usual (TAU).
Control group
OTHERParticipants will undergo TAU. The content of TAU is broadly individualized but most often includes various forms of group therapy, psychotherapy, psychoeducation and physical activity. The physical activity schedule for the patients typically includes gym-based exercises, individualized by preference of each patient, and various outdoors activities, four times per week all together.
Interventions
Supervised exercise intervention, three times a week for eight weeks.
The content of TAU is broadly individualized but most often includes various forms of group therapy, psychotherapy, psychoeducation and physical activity. The physical activity schedule for the patients typically includes gym-based exercises, individualized by preference of each patient, and various outdoors activities, four times per week all together.
Eligibility Criteria
You may qualify if:
- Diagnosed substance use disorder (SUD) by ICD-10
- Being in residential inpatient treatment for SUD at Lade Addiction Treatment Center
You may not qualify if:
- Recent participation in regular aerobic high-intensity interval training (HIIT)
- Admissions shorter than 12 weeks
- Pregnant
- History of brain injury (except concussions)
- Any acute or chronic somatic or psychiatric condition (e.g. heart disease or psychosis) or a medication that would limit the ability to participate in the exercise training and testing procedures, or any of the other assessments.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- St. Olavs Hospitallead
- Norwegian University of Science and Technologycollaborator
- Lade Behandlingssenter, Blå Korscollaborator
Study Sites (1)
Lade Behandlingssenter, Blåkors
Trondheim, Trøndelag, 7041, Norway
Related Publications (1)
Haberstroh C, Weider S, Flemmen G, Loe H, Andersson HW, Hallgren M, Mosti MP. The effect of high-intensity interval training on cognitive function in patients with substance use disorder: Study protocol for a two-armed randomized controlled trial. Front Sports Act Living. 2022 Dec 9;4:954561. doi: 10.3389/fspor.2022.954561. eCollection 2022.
PMID: 36570498DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mats P Mosti, PhD
Department of Research and Development, St. Olavs University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 4, 2022
First Posted
April 12, 2022
Study Start
April 7, 2022
Primary Completion
December 20, 2024
Study Completion
December 20, 2024
Last Updated
June 10, 2025
Record last verified: 2025-06